相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ADOPTIVE TRANSFER OF RAPIDLY-GENERATED MULTIVIRUS-SPECIFIC T CELLS TO TREAT ADENOVIRUS, EBV AND CMV INFECTIONS OF HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
U. Gerdemann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation
Karl S. Peggs et al.
CLINICAL INFECTIOUS DISEASES (2011)
Immune defence against EBV and EBV-associated disease
Heather M. Long et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination
Leslie E. Huye et al.
MOLECULAR THERAPY (2011)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation
Anita Schmitt et al.
TRANSFUSION (2011)
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Helen E. Heslop et al.
BLOOD (2010)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
Andreas Moosmann et al.
BLOOD (2010)
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
Tobias Feuchtinger et al.
BLOOD (2010)
Allo-HLA reactivity of virus-specific memory T cells is common
Avital L. Amir et al.
BLOOD (2010)
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Alessandro Fantin et al.
BLOOD (2010)
Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines
Anne Parker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines
Anne Parker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Michael Uhlin et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder
Margaret L. Gulley et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Non-Hodgkin's Lymphomas
Andrew D. Zelenetz et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Posttransplant Lymphoproliferative Diseases
Thomas G. Gross et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease
Jennifer Brewin et al.
BLOOD (2009)
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
Biagio De Angelis et al.
BLOOD (2009)
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Ola Landgren et al.
BLOOD (2009)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Fabio Ciceri et al.
LANCET ONCOLOGY (2009)
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
Ulrike Gerdemann et al.
MOLECULAR THERAPY (2009)
Lymphoproliferative Disorders and De Novo Malignancies in Intestinal and Multivisceral Recipients: Improved Outcomes With New Outlooks
Kareem M. Abu-Elmagd et al.
TRANSPLANTATION (2009)
The curious case of the tumour virus: 50 years of Burkitt's lymphoma
David A. Thorley-Lawson et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Prospective study of sequential reduction in immunosuppression, interferon alpha-2b, and chemotherapy for posttransplantation lymphoproliferative disorder
Lode J. Swinnen et al.
TRANSPLANTATION (2008)
Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality
David A. Thorley-Lawson et al.
TRENDS IN IMMUNOLOGY (2008)
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Catherine M. Bollard et al.
BLOOD (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation
P. Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Immunity, homing and efficacy of allogeneic adoptive immunotherapy for posttransplant lymphoproliferative disorders
M. K. Gandhi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens
Julia Neudorfer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Treatment of solid organ transplant recipients with autologolus Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)
Barbara Savoldo et al.
BLOOD (2006)
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
Claudio G. Brunstein et al.
BLOOD (2006)
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
Ann M. Leen et al.
NATURE MEDICINE (2006)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Treatment of EBV-related post-renal transplant lymphoproliferative disease with a tailored regimen including EBV-Specific T cells
P Comoli et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning
J Cohen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease
B Savoldo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies
R Khanna et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Post-transplant lymphoproliferative disorders
S Gottschalk et al.
ANNUAL REVIEW OF MEDICINE (2005)
Mechanisms of disease - Persistence of the Epstein-Barr virus and the origins of associated lymphomas
DA Thorley-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines
KS Peggs et al.
LANCET (2003)
Impaired recovery of Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease
P Meij et al.
BLOOD (2003)
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy
MA Sherritt et al.
TRANSPLANTATION (2003)
Lymphomas occurring late after solid-organ transplantation - Influence of treatment on the clinical outcome
G Dotti et al.
TRANSPLANTATION (2002)
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma
Q Sun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation
JWJ van Esser et al.
BLOOD (2002)
Adapting a transforming growth factor β-related tumor protection strategy to enhance antitumor immunity
CM Bollard et al.
BLOOD (2002)
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
PA Carpenter et al.
BLOOD (2002)
Infusion of autologous Epstein-Barr virus (EBV) -: specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication
P Comoli et al.
BLOOD (2002)
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells
T Haque et al.
TRANSPLANTATION (2001)
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk et al.
BLOOD (2001)
Epstein-Barr virus infection.
JI Cohen
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
